Clinical Research Associate
Alexion
Clinical Research Associate
Alexion
Global biopharmaceuticals focusing on rare diseases
[Job Description]
The Clinical Research Associate (CRA) has local responsibility for the delivery of the studies at their assigned sites and is an active participant in the local study team(s). The CRA works in close collaboration with local team members (Project Management Clinical Operations (PMCO), Study Start-Up (SSU) manager, Clinical Study Assistant (CSA) and other CRAs in Clinical Operations Management (COM) to ensure that study commitments are achieved in a timely and efficient manner on a site level. The CRA acts as the main contact with the study site and has the responsibility for monitoring the study conduct to ensure delivery and compliance. The CRA is responsible for the identification, selection, initiation, monitoring and closure of assigned sites in clinical studies, in compliance with Alexion Procedural Documents, international guidelines such as ICH-GCP, and relevant local regulations, and that the sites deliver according to their respective commitment in the individual studies. A CRA with demonstrated skillset and experience may take on additional study level responsibilities and tasks as needed (e.g. Lead CRA, etc).
[Typical Accountabilities]
You will be responsible for:
[Skills]
You will need to have:
We would prefer for you to have:
[Qualifications]
-Education: Bachelors degree in related discipline, preferably in life science, or equivalent qualification
-Language: Excellent written and verbal communication skills (both in English and local language)
-Certifications: GCP/work related certificate preferred
-Work Experience: Minimum of 1 years of CRA monitoring experience
※ 채용 절차법에 따른 고지 사항
1. 전자우편으로제출한서류는채용절차법에따라, 일체반환의무가없습니다.
2. 보훈대상자 및 취업보호대상자는관련법에의거하여우대합니다.
3. 해외여행결격사유가없어야합니다.
4. 본 채용은수시진행으로, 우수인력채용 시 마감될 수 있습니다.
Date Posted
01-8월-2025Closing Date
Alexion is proud to be an Equal Employment Opportunity and Affirmative Action employer. We are committed to fostering a culture of belonging where every single person can belong because of their uniqueness. The Company will not make decisions about employment, training, compensation, promotion, and other terms and conditions of employment based on race, color, religion, creed or lack thereof, sex, sexual orientation, age, ancestry, national origin, ethnicity, citizenship status, marital status, pregnancy, (including childbirth, breastfeeding, or related medical conditions), parental status (including adoption or surrogacy), military status, protected veteran status, disability, medical condition, gender identity or expression, genetic information, mental illness or other characteristics protected by law. Alexion provides reasonable accommodations to meet the needs of candidates and employees. To begin an interactive dialogue with Alexion regarding an accommodation, please contact [email protected]. Alexion participates in E-Verify.
Alexion, now the rare disease group within AstraZeneca, develops and sells therapies for rare and ultra-rare diseases by targeting the complement immune system. Its drugs, such as Soliris and Ultomiris, inhibit the C5 component to slow or stop disease processes, while Strensiq and Kanuma address specific metabolic disorders. It differentiates itself through a deep focus on complement biology, pursuing first- or best-in-class therapies, and using a strategy that blends internal R&D with acquisitions to expand its pipeline. Its goal is to improve outcomes for patients with rare diseases and bring these therapies to a broader international market using AstraZeneca’s scale and capabilities.
Explore more opportunities at Alexion